Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice.

Genes affecting autoimmune type 1 diabetes susceptibility in the nonobese diabetic (NOD) mouse (Idd loci) have been mapped using a congenic strain breeding strategy. In the present study, we used a combination of BAC clone contig construction, polymorphism analysis of DNA from congenic strains, and sequence mining of the human orthologous region to generate an integrated map of the Idd10 region on mouse chromosome 3. We found seven genes and one pseudogene in the 950-kb Idd10 region. Although all seven genes in the interval are Idd10 candidates, we suggest the gene encoding the EWI immunoglobulin subfamily member EWI-101 (Cd101) as the most likely Idd10 candidate because of the previously reported immune-associated properties of the human CD101 molecule. Additional support for the candidacy of Cd101 is the presence of 17 exonic single-nucleotide polymorphisms that differ between the NOD and B6 sequences, 10 causing amino acid substitutions in the predicted CD101 protein. Four of these 10 substitutions are nonconservative, 2 of which could potentially alter N-linked glycosylation. Considering our results together with those previous reports that antibodies recognizing human CD101 modulate human T-cell and dendritic cell function, there is now justification to test whether the alteration of CD101 function affects autoimmune islet destruction.

[1]  J. Todd,et al.  Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. , 1997, Journal of immunology.

[2]  A. Aruffo,et al.  Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease. , 2001, Current opinion in immunology.

[3]  P. D. de Jong,et al.  Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. , 2000, Genome research.

[4]  J. Todd,et al.  Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. , 2000, Genome research.

[5]  A. Theofilopoulos.  Genes and genetics of autoimmunity , 1999 .

[6]  D. Serreze,et al.  Transgenic rescue implicates β2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Todd,et al.  Mapping of the IDDM Locus Idd3 to a 0.35-cM Interval Containing the Interleukin-2 Gene , 1997, Diabetes.

[8]  K. Blenman,et al.  The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Todd,et al.  NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. , 2000, Diabetes.

[10]  J. Todd,et al.  Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes , 1994, The Journal of experimental medicine.

[11]  Krista L. Clark,et al.  PGRL Is a Major CD81-Associated Protein on Lymphocytes and Distinguishes a New Family of Cell Surface Proteins1 , 2001, The Journal of Immunology.

[12]  J. Todd,et al.  The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. , 2000, Immunity.

[13]  E. Engleman,et al.  V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation. , 1998, Journal of immunology.

[14]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[15]  Linda S. Wicker,et al.  NOD Idd 5 Locus Controls Insulitis and Diabetes and Overlaps the Orthologous CTLA 4 / IDDM 12 and NRAMP 1 Loci in Humans , 2000 .

[16]  Eric S. Lander,et al.  The mosaic structure of variation in the laboratory mouse genome , 2002, Nature.

[17]  J. Todd,et al.  Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse. , 2001, Diabetes.

[18]  P. Lyons,et al.  Localising quantitative trait loci in the NOD mouse model of type 1 diabetes. , 1999, Current directions in autoimmunity.

[19]  C. Soderlund,et al.  Contigs built with fingerprints, markers, and FPC V4.7. , 2000, Genome research.

[20]  T. V. Kolesnikova,et al.  EWI-2 Is a Major CD9 and CD81 Partner and Member of a Novel Ig Protein Subfamily* , 2001, The Journal of Biological Chemistry.

[21]  E. Ebert,et al.  p126 (CDw101), a costimulatory molecule preferentially expressed on mucosal T lymphocytes. , 1996, Journal of immunology.

[22]  E. Engleman,et al.  Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism. , 1997, Journal of immunology.

[23]  M. Bagot,et al.  Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL‐10 production , 2000, European journal of immunology.

[24]  J. Egen,et al.  Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. , 2002, Immunity.

[25]  G. Freeman,et al.  CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. , 1997, Tissue antigens.

[26]  R. Warnke,et al.  V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. , 1995, Journal of immunology.